WO2001045678A3 - Arzneimittel, verfahren zu dessen herstellung und dessen verwendung - Google Patents
Arzneimittel, verfahren zu dessen herstellung und dessen verwendung Download PDFInfo
- Publication number
- WO2001045678A3 WO2001045678A3 PCT/EP2000/013036 EP0013036W WO0145678A3 WO 2001045678 A3 WO2001045678 A3 WO 2001045678A3 EP 0013036 W EP0013036 W EP 0013036W WO 0145678 A3 WO0145678 A3 WO 0145678A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- production
- medicament
- compound
- composition
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/58—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU31620/01A AU3162001A (en) | 1999-12-21 | 2000-12-20 | Medicament, a method for its production and the use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19961834 | 1999-12-21 | ||
DE19961834.8 | 1999-12-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001045678A2 WO2001045678A2 (de) | 2001-06-28 |
WO2001045678A3 true WO2001045678A3 (de) | 2002-04-11 |
Family
ID=7933684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/013036 WO2001045678A2 (de) | 1999-12-21 | 2000-12-20 | Arzneimittel, verfahren zu dessen herstellung und dessen verwendung |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3162001A (de) |
WO (1) | WO2001045678A2 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8945558B2 (en) | 2005-10-21 | 2015-02-03 | Chugai Seiyaku Kabushiki Kaisha | Methods for treating myocardial infarction comprising administering an IL-6 inhibitor |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0105944D0 (en) * | 2001-03-10 | 2001-04-25 | Royal Devon & Exeter Healthcar | Anaesthetic Formulation |
ES2214126B1 (es) * | 2003-01-20 | 2006-02-16 | Montserrat Torne Cabanes | Nueva formulacion para anestesia topica, su correspondiente kit monodosis y sus aplicaciones en cirugia. |
DE10303669A1 (de) * | 2003-01-28 | 2004-07-29 | Hans-Knöll-Institut für Naturstoff-Forschung e.V. | Tetraalkylammoniumsalze vom Kohlensäureestertyp, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
AU2006300234B2 (en) | 2005-10-14 | 2013-01-10 | Chugai Seiyaku Kabushiki Kaisha | Agents for suppressing damage to transplanted islets after islet transplantation |
AR057582A1 (es) | 2005-11-15 | 2007-12-05 | Nat Hospital Organization | Agentes para suprimir la induccion de linfocitos t citotoxicos |
CN104189907A (zh) | 2006-01-27 | 2014-12-10 | 学校法人庆应义塾 | 伴有脉络膜血管生成的疾病的治疗药 |
EP2025346B1 (de) * | 2006-04-07 | 2016-08-10 | Osaka University | Mittel zur förderung der muskelregeneration |
DK2101819T3 (da) | 2006-11-20 | 2013-04-29 | Harvard College | Fremgangsmåder, sammensætninger og kits til behandling af smerte og pruritis |
MX2009007830A (es) | 2007-01-23 | 2009-10-07 | Univ Shinshu | Inhibidor de rechazo cronico. |
JP5276020B2 (ja) * | 2007-02-13 | 2013-08-28 | カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ | カチオン性エストラジオール誘導体、その合成方法、及び医薬組成物 |
US10717781B2 (en) | 2008-06-05 | 2020-07-21 | National Cancer Center | Neuroinvasion inhibitor |
EP3485881B1 (de) | 2009-07-10 | 2024-03-13 | President and Fellows of Harvard College | Permanent geladene natrium- und calciumkanalblocker als entzündungshemmende mittel |
ES2932398T3 (es) | 2010-05-28 | 2023-01-18 | Chugai Pharmaceutical Co Ltd | Potenciador de la respuesta de las células T antitumorales |
CN105315170B (zh) * | 2014-08-01 | 2017-08-25 | 四川大学华西医院 | 二甲基苯铵类长链化合物、制备、自组装结构及用途 |
CA2994545A1 (en) | 2015-08-03 | 2017-02-09 | President And Fellows Of Harvard College | Charged ion channel blockers and methods for use |
WO2018203545A1 (ja) | 2017-05-02 | 2018-11-08 | 国立研究開発法人国立精神・神経医療研究センター | Il-6及び好中球の関連する疾患の治療効果の予測及び判定方法 |
EP3698808A4 (de) | 2017-10-20 | 2021-07-14 | Hyogo College Of Medicine | Anti-il-6 rezeptorantikörper enthaltende medizinische zusammensetzung zur verhinderung von postoperativer adhäsion |
CN109574866B (zh) * | 2019-01-15 | 2022-07-15 | 中国科学院成都有机化学有限公司 | 一种2,6-二甲基苯胺类长链化合物的制备方法 |
KR20210145164A (ko) | 2019-03-11 | 2021-12-01 | 녹시온 테라퓨틱스 인코포레이티드 | 에스테르 치환된 이온 채널 차단제 및 사용 방법 |
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
JP2022525856A (ja) | 2019-03-11 | 2022-05-20 | ノシオン セラピューティクス,インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
CA3129117A1 (en) | 2019-03-11 | 2020-09-17 | Bridget Mccarthy Cole | Charged ion channel blockers and methods for use |
IL292505A (en) | 2019-11-06 | 2022-06-01 | Nocion Therapeutics Inc | Charged ion channel blockers and methods of use |
EP4054586A4 (de) | 2019-11-06 | 2023-11-22 | Nocion Therapeutics, Inc. | Geladene ionenkanalblocker und verfahren zur verwendung |
AU2021236130A1 (en) | 2020-03-11 | 2022-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1279214A (en) * | 1970-01-22 | 1972-06-28 | Forest Laboratories | Long-acting oral carrier |
US3821375A (en) * | 1970-11-05 | 1974-06-28 | Alper C | Treatment of otitis of dogs and cats with chloramphenicol-squalane composition |
JPS5576814A (en) * | 1978-12-06 | 1980-06-10 | Green Cross Corp:The | Preservative solution for organ transplant |
EP0035856A2 (de) * | 1980-03-07 | 1981-09-16 | Efamol Limited | Pharmazeutische und diätetische Zusammensetzungen |
US4446140A (en) * | 1981-12-10 | 1984-05-01 | Nelson Research & Development Company | Method and composition for treating mouth pain |
JPS6450815A (en) * | 1987-08-21 | 1989-02-27 | Ajinomoto Kk | Plaster for oral cavity application |
RU1824187C (ru) * | 1990-04-09 | 1993-06-30 | Харьковский Медицинский Институт | Способ лечени миастении |
CN1092987A (zh) * | 1993-04-02 | 1994-10-05 | 中国人民解放军81378部队医院 | 椎管去炎混合液 |
CN1114190A (zh) * | 1994-06-07 | 1996-01-03 | 周波 | 高分子合成材料重睑术混合处理液 |
JPH08245369A (ja) * | 1995-03-08 | 1996-09-24 | Tendou Seiyaku Kk | 粘膜保護剤 |
US5589156A (en) * | 1994-05-02 | 1996-12-31 | Henry; Richard A. | Prilocaine and hydrofluourocarbon aerosol preparations |
CN1185975A (zh) * | 1997-07-31 | 1998-07-01 | 占汝兴 | 痤疮药水 |
DE19715594A1 (de) * | 1997-04-15 | 1998-10-22 | Bayer Ag | Analgetika-Kombination |
-
2000
- 2000-12-20 WO PCT/EP2000/013036 patent/WO2001045678A2/de active Application Filing
- 2000-12-20 AU AU31620/01A patent/AU3162001A/en not_active Abandoned
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1279214A (en) * | 1970-01-22 | 1972-06-28 | Forest Laboratories | Long-acting oral carrier |
US3821375A (en) * | 1970-11-05 | 1974-06-28 | Alper C | Treatment of otitis of dogs and cats with chloramphenicol-squalane composition |
JPS5576814A (en) * | 1978-12-06 | 1980-06-10 | Green Cross Corp:The | Preservative solution for organ transplant |
EP0035856A2 (de) * | 1980-03-07 | 1981-09-16 | Efamol Limited | Pharmazeutische und diätetische Zusammensetzungen |
US4446140A (en) * | 1981-12-10 | 1984-05-01 | Nelson Research & Development Company | Method and composition for treating mouth pain |
JPS6450815A (en) * | 1987-08-21 | 1989-02-27 | Ajinomoto Kk | Plaster for oral cavity application |
RU1824187C (ru) * | 1990-04-09 | 1993-06-30 | Харьковский Медицинский Институт | Способ лечени миастении |
CN1092987A (zh) * | 1993-04-02 | 1994-10-05 | 中国人民解放军81378部队医院 | 椎管去炎混合液 |
US5589156A (en) * | 1994-05-02 | 1996-12-31 | Henry; Richard A. | Prilocaine and hydrofluourocarbon aerosol preparations |
CN1114190A (zh) * | 1994-06-07 | 1996-01-03 | 周波 | 高分子合成材料重睑术混合处理液 |
JPH08245369A (ja) * | 1995-03-08 | 1996-09-24 | Tendou Seiyaku Kk | 粘膜保護剤 |
DE19715594A1 (de) * | 1997-04-15 | 1998-10-22 | Bayer Ag | Analgetika-Kombination |
CN1185975A (zh) * | 1997-07-31 | 1998-07-01 | 占汝兴 | 痤疮药水 |
Non-Patent Citations (7)
Title |
---|
DATABASE EPODOC EUROPEAN PATENT OFFICE, THE HAGUE, NL; XP002170398 * |
DATABASE EPODOC EUROPEAN PATENT OFFICE, THE HAGUE, NL; XP002170400 * |
DATABASE WPI Section Ch Week 199444, Derwent World Patents Index; Class B05, AN 1994-356522, XP002170399 * |
DATABASE WPI Section Ch Week 199717, Derwent World Patents Index; Class B05, AN 1997-180058, XP002170401 * |
PATENT ABSTRACTS OF JAPAN vol. 004, no. 124 (C - 023) 2 September 1980 (1980-09-02) * |
PATENT ABSTRACTS OF JAPAN vol. 013, no. 238 (C - 603) 5 June 1989 (1989-06-05) * |
PATENT ABSTRACTS OF JAPAN vol. 1997, no. 01 31 January 1997 (1997-01-31) * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8945558B2 (en) | 2005-10-21 | 2015-02-03 | Chugai Seiyaku Kabushiki Kaisha | Methods for treating myocardial infarction comprising administering an IL-6 inhibitor |
Also Published As
Publication number | Publication date |
---|---|
AU3162001A (en) | 2001-07-03 |
WO2001045678A2 (de) | 2001-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001045678A3 (de) | Arzneimittel, verfahren zu dessen herstellung und dessen verwendung | |
HK1031869A1 (en) | 1-Ä(1-Substituted-4-piperidinyl)methylÜ-4-piperdine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds. | |
HK1047575A1 (en) | Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same. | |
HK1048122A1 (en) | Method for the preparation of citalopram. | |
AU4949800A (en) | 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives | |
HUP0203496A3 (en) | Novel cyclopropane derivatives, pharmaceutical compositions containing them and method for the production thereof | |
WO2001010816A3 (de) | Substituierte 2-Dialkylaminoalkylbiphenyl-derivate | |
AU3156600A (en) | Novel epothilon derivatives, method for the production thereof and their pharmaceutical application | |
HUP9901616A3 (en) | Novel benzofuranone derivatives, process for their production and pharmaceutical compositions of the same | |
BG105197A (en) | Polymorph form of a medicament | |
AU2001282174A1 (en) | Method for the production of xylitol | |
AU2001292331A1 (en) | 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation | |
AU2001292331A2 (en) | 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation | |
WO2001000577A3 (en) | Preparation of substituted piperidin-4-ones | |
AU3825700A (en) | Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines | |
AU2003286944A1 (en) | Crude drug compositions and the process for preparing them | |
AU2002330042A1 (en) | Process for the preparation of 1,5-diarylpyrazoles | |
AU2001272368A1 (en) | Method for the preparation of citalopram | |
AU1651001A (en) | Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof | |
AU1606997A (en) | Novel naphthylpiperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions and use thereof as drugs | |
AU6870600A (en) | Process for the preparation of 2,3-dihydroazepine compounds | |
AU2002222695A1 (en) | Novel 4'-demethyl-4'-o-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same | |
AU6870500A (en) | Process for the preparation of 2,3-dihydroazepine derivatives | |
AU7773900A (en) | Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds | |
WO2000029015A3 (de) | BEEINFLUSSUNG DER ANGIOGENESE DURCH CD66a |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |